Aimmune Therapeutics Inc (AIMT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

8000 MARINA BOULEVARD BRISBANE, CA 94005-1884

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers worldwide.

Data as of 2019-12-03 02:27:52 -0500
Market Cap1.765 Billion Shares Outstanding63.3 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-3.867
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low29.68 / 16.95 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from AIMT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 9 -100.0% 0 (0.0%) 6 (0.37%) -100.0%
Funds Holding: 1 185 -99.46% (0.0%) 67 (4.17%)
13F shares: 38.944 Thousand 43.565 Million -99.91% 0 20.352 Million -100.0%
% Ownership 66.5614 31.0949
New Positions: 85 40
Increased Positions 29 8
Closed Positions 182 59 208.47% 67 17 294.12%
Reduced Positions 50 16
Total Calls 0 1.418 Million -100.0% 0 389.3 Thousand -100.0%
Total Puts 0 1.087 Million -100.0% 0 553.366 Thousand -100.0%
PUT/CALL Ratio 0.77 1.42
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AIMT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AIMT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BEHAR GREGORY

  • Director
0 2020-10-13 2

SOCIETE DES PRODUITS NESTLE S.A.

  • 10% Owner
80,097,147 2020-10-13 1

MCDADE MARK

  • Director
0 2020-10-10 2

SELTZER STACEY DENENBERG

  • Director
0 2020-10-10 2

ENRIGHT PATRICK G

  • Director
0 2020-10-10 3

FALBERG KATHRYN E

  • Director
0 2020-10-10 2

IWICKI MARK T

  • Director
0 2020-10-10 2

SHEEHY DOUGLAS T. SEE REMARKS

  • Officer
0 2020-10-10 3

ADELMAN DANIEL C MD CHIEF MEDICAL OFFICER

  • Officer
0 2020-10-10 3

BJERKHOLT ERIC CHIEF FINANCIAL OFFICER

  • Officer
0 2020-10-10 3

DALLAS JAYSON DONALD ALEXANDER PRESIDENT AND CEO

  • Officer
  • Director
0 2020-10-10 3

HAUMANN BRETT K

  • Director
0 2020-10-10 2

OXTOBY ANDREW CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-10-10 2

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

  • 10% Owner
26,505,494 2020-02-07 1

ROZENMAN MARY M. SEE REMARKS

  • Officer
13,878 2019-12-31 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

NIMCO US, INC.

NESTLE US HOLDCO, INC.

  • 10% Owner
11,727,113 2018-12-31 0

BARROWCLIFFE SUSAN E. GENERAL MANAGER, EUROPE

  • Officer
9,375 2018-11-19 0

DILLY STEPHEN GEORGE PRESIDENT AND CEO

  • Officer
  • Director
447,008 2018-06-11 0

KNAPP JEFFREY H CHIEF OPERATING OFFICER

  • Officer
12,151 2018-03-04 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

NESTLE SA

NIMCO US, INC.

  • 10% Owner
11,727,113 2018-02-26 0

TAMMENOMS BAKKER JULIET

  • 10% Owner
6,029,785 2018-02-22 0

DESOUZA WARREN L. CHIEF FINANCIAL OFFICER

  • Officer
20,681 2017-04-03 0

LONGITUDE CAPITAL PARTNERS II, LLC

TAMMENOMS BAKKER JULIET

LONGITUDE VENTURE PARTNERS II, L.P.

  • 10% Owner
6,020,410 2016-11-29 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

TANANBAUM JAMES B.

  • 10% Owner
4,902,920 2016-08-18 0

LONGITUDE CAPITAL PARTNERS II, LLC

LONGITUDE VENTURE PARTNERS II, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

  • 10% Owner
7,513,134 2016-03-29 0

ELFONT ROBERT MYLES CHIEF MEDICAL OFFICER

  • Officer
299,002 2016-02-26 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

TANANBAUM JAMES B.

  • 10% Owner
0 2015-08-05 0

RAFF HOWARD V. CHIEF OPERATING OFFICER

  • Officer
428,575 2015-08-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund AIMT -112.0 shares, $-1615.04 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund AIMT -228.0 shares, $-3287.76 2020-03-31 N-PORT

Elevate your investments